Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients

BACKGROUND: Myocardial utilization of 3-hydroxybutyrate (3-OHB) is increased in patients with heart failure and reduced ejection fraction (HFrEF). However, the cardiovascular effects of increased circulating plasma-3-OHB levels in these patients are unknown. Consequently, the authors’ aim was to mod...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Circulation
Päätekijät: Nielsen, Roni, Møller, Niels, Gormsen, Lars C., Tolbod, Lars Poulsen, Hansson, Nils Henrik, Sorensen, Jens, Harms, Hendrik Johannes, Frøkiær, Jørgen, Eiskjaer, Hans, Jespersen, Nichlas Riise, Mellemkjaer, Søren, Lassen, Thomas Ravn, Pryds, Kasper, Bøtker, Hans Erik, Wiggers, Henrik
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Lippincott Williams & Wilkins 2019
Aiheet:
Original Research Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6493702/
https://ncbi.nlm.nih.gov/pubmed/30884964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.118.036459
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia